These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 769454)

  • 1. [Relations between the macrophage electrophoretic mobility test and the rhodanide level in patients with malignant tumors, autoaggression diseases and after transplantation].
    Jülich WD; Weuffen W; Jenssen HL; Köhler H
    Acta Biol Med Ger; 1975; 34(9):1541-7. PubMed ID: 769454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the influence of electrolytes upon immunization processes. I. Immunological reactivity as a function of the rhodanide level in guinea pigs sensitized with horse serum].
    Weuffen W; Jülich WD; Bohnenstengel C; Wagner R; Weber P
    Acta Biol Med Ger; 1974; 32(2-3):249-60. PubMed ID: 4418884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological after-care in kidney transplantation].
    Friemel H
    Zentralbl Chir; 1975; 100(20):1241-6. PubMed ID: 174341
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
    Light PA; Preece AW; Waldron HA
    Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the rhodanide level and antibody titer in the guinea pig].
    Weuffen W; JULICH W-D ; Bohnenstengel C
    Allerg Immunol (Leipz); 1973; 19(2-4):166-72. PubMed ID: 4281618
    [No Abstract]   [Full Text] [Related]  

  • 10. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 11. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
    Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
    Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage electrophoretic mobility test for brain tumors and malignancies.
    Yongde S; Zhensheng T; Chuanshen L; Baoguo X; Zijun L; Yifei S; Yanfang J; Xindi Y; Meizhen L; Xuezhen S
    Chin Med J (Engl); 1979 Mar; 92(3):211-5. PubMed ID: 109261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunodiagnosis of malignant tumors. Test of electrophoretic mobility of macrophages].
    Strejcek J; Jíra M; Suhajová E; Písa P; Malbohan I
    Cas Lek Cesk; 1984 Apr; 123(17):511-6. PubMed ID: 6380732
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunosuppressive activity of ara-C (cytarabine) and derivatives.
    Gray GD
    Transplant Proc; 1973 Sep; 5(3):1203-9. PubMed ID: 4147026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complement in the blood of patients after kidney transplantation].
    Korenevskaia VA; Shumakov VI; Levitskiĭ ER; Goriaĭnov VA; Polishchuk RV
    Sov Med; 1973 Oct; 36(10):59-62. PubMed ID: 4596825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
    Zhao BH; Hu JK; Liang JX
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
    Nakajima T; Isojima K; Iwaguchi T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical application of macrophage migration inhibition test].
    Akiyama T; Yamaura N
    Rinsho Byori; 1973 Jan; 21(1):52-8. PubMed ID: 4575082
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant tumors following kidney transplantation. Experiences at the tranplantation center in Zurich].
    Wegmann W; Largiadèr F; Binswanger U
    Schweiz Med Wochenschr; 1974 Jun; 104(23):809-14. PubMed ID: 4601389
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of lymphocyte transfer reactions in experimentally auto-immunised animals.
    Gupta KD; Jatkar PR; Agarwal RG; Narula SK
    J Assoc Physicians India; 1971 Aug; 19(8):567-70. PubMed ID: 5118236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.